Browsing Over 400 Presentations

Sort By
HHH Award Keynote Lecture Keynote Lecture

The power of the multiple H

Lecture Time
13:45 - 14:15
Presenter
  • Fabrice Barlesi (FR)
Session Name
HHH Award Keynote Lecture
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
13:45 - 14:15
Authors
  • Fabrice Barlesi (FR)
First line for oncogene addicted lung cancer Educational session

Is PFS still a relevant endpoint for first-line TKIs?

Lecture Time
14:30 - 14:50
Presenter
  • Suresh S. Ramalingam (US)
Session Name
First line for oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Suresh S. Ramalingam (US)
First line for oncogene addicted lung cancer Educational session

First vs second vs third generation EGFR TKI

Lecture Time
14:50 - 15:10
Presenter
  • Juergen Wolf (DE)
Session Name
First line for oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Juergen Wolf (DE)
First line for oncogene addicted lung cancer Educational session

Key factors that determine the selection of first-line ALK inhibtiors

Lecture Time
15:10 - 15:30
Presenter
  • Fiona H. Blackhall (GB)
Session Name
First line for oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Fiona H. Blackhall (GB)
First line for oncogene addicted lung cancer Educational session

The role of first-line combination therapy for oncogene addicted lung cancer

Lecture Time
15:30 - 15:50
Presenter
  • Takashi Seto (JP)
Session Name
First line for oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Takashi Seto (JP)
First line for oncogene addicted lung cancer Educational session

Q&A

Lecture Time
15:50 - 16:00
Session Name
First line for oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Combined treatment stage III Educational session

When concurrent chemo-radiotherapy is not the preferred choice

Lecture Time
14:30 - 14:50
Presenter
  • Pierre Fournel (FR)
Session Name
Combined treatment stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Pierre Fournel (FR)
Combined treatment stage III Educational session

Are current NTCP models useful for predicting radiation-induced toxicity?

Lecture Time
14:50 - 15:10
Presenter
  • Dirk De Ruysscher (NL)
Session Name
Combined treatment stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Dirk De Ruysscher (NL)
Combined treatment stage III Educational session

Surgical salvage of recurrences following CT-RT: Indications and outcomes

Lecture Time
15:10 - 15:30
Presenter
  • Chris Dickhoff (NL)
Session Name
Combined treatment stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Chris Dickhoff (NL)
Combined treatment stage III Educational session

Immunotherapy in the stage III paradigm: Rationale and clinical data

Lecture Time
15:30 - 15:50
Presenter
  • Solange Peters (CH)
Session Name
Combined treatment stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Solange Peters (CH)
Combined treatment stage III Educational session

Q&A

Lecture Time
15:50 - 16:00
Session Name
Combined treatment stage III
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
First line for non-oncogene addicted lung cancer Educational session

First-line chemotherapy in NSCLC: Where do we stand?

Lecture Time
16:30 - 16:50
Presenter
  • Rolf A. Stahel (CH)
Session Name
First line for non-oncogene addicted lung cancer
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
16:30 - 18:00
Authors
  • Rolf A. Stahel (CH)